21071498

Source:http://linkedlifedata.com/resource/pubmed/id/21071498

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017725, umls-concept:C0023473, umls-concept:C0036576, umls-concept:C0242184, umls-concept:C0470187, umls-concept:C0683598, umls-concept:C0851285, umls-concept:C0870134, umls-concept:C1515021
pubmed:issue	2
pubmed:dateCreated	2011-2-1
pubmed:abstractText	Incubation of chronic myeloid leukemia cells in hypoxia inhibits growth and selects BCR/Abl-independent cells with stem cell properties which are refractory to imatinib-mesylate. This study aimed to characterize the relationship of this refractoriness with glucose availability in the environment.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-10691876, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-10764163, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-11134568, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-11756187, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-11823039, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-12110704, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-12393432, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-12576334, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-14712293, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-14744784, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-15342936, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-15719031, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-16321820, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-16469872, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-16710305, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-17255519, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-17311290, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-17330101, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-17374716, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-18256528, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-18273048, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-18385684, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-19039626, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-19725055, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-20053753, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-20068223, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-3817047, http://linkedlifedata.com/resource/pubmed/commentcorrection/21071498-8104535
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0417435
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Fusion Proteins, bcr-abl, http://linkedlifedata.com/resource/pubmed/chemical/Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Piperazines, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/Sweetening Agents, http://linkedlifedata.com/resource/pubmed/chemical/imatinib
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1592-8721
pubmed:author	pubmed-author:BarbettiValentinaV, pubmed-author:Dello SbarbaPersioP, pubmed-author:Di GesualdoFedericoF, pubmed-author:GiuntoliSerenaS, pubmed-author:RovidaElisabettaE, pubmed-author:TanturliMicheleM
pubmed:issnType	Electronic
pubmed:volume	96
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	204-12
pubmed:meshHeading	pubmed-meshheading:21071498-Anoxia, pubmed-meshheading:21071498-Apoptosis, pubmed-meshheading:21071498-Cell Proliferation, pubmed-meshheading:21071498-Drug Resistance, Neoplasm, pubmed-meshheading:21071498-Fusion Proteins, bcr-abl, pubmed-meshheading:21071498-Glucose, pubmed-meshheading:21071498-Humans, pubmed-meshheading:21071498-Leukemia, Myelogenous, Chronic, BCR-ABL Positive, pubmed-meshheading:21071498-Neoplastic Stem Cells, pubmed-meshheading:21071498-Piperazines, pubmed-meshheading:21071498-Protein Kinase Inhibitors, pubmed-meshheading:21071498-Pyrimidines, pubmed-meshheading:21071498-Sweetening Agents, pubmed-meshheading:21071498-Tumor Cells, Cultured
pubmed:year	2011
pubmed:articleTitle	Glucose availability in hypoxia regulates the selection of chronic myeloid leukemia progenitor subsets with different resistance to imatinib-mesylate.
pubmed:affiliation	Dipartimento di Patologia e Oncologia Sperimentali, Università degli Studi di Firenze and Istituto Toscano Tumori, Viale G.B. Morgagni 50, I-50134, Firenze, Italia.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't